AU StockDetailed Quotes

Provided by Tiger Fintech (Singapore) Pte. Ltd.

ONCOSIL MEDICAL LTD

0.006

+0.00120.00%

Volume:11.30M

Turnover:56.52K

Market Cap:27.58M

PE:-1.51

High:0.006

Open:0.005

Low:0.004

Close:0.005

Loading ...

Overview Company News Filings

OncoSil Medical Says 120 German Hospitals Secure Authorization to Negotiate Fee for Cancer Treatment Device; Shares Surge 40%

MT Newswires Live

OncoSil Medical Receives Medical Device Regulation Certification; Shares Surge 20%

MT Newswires Live

BRIEF-Oncosil Medical Receives Mdr Approval

Oncosil Medical Ltd - Oncosil Medical Receives mDR Approval

THOMSON REUTERS

ASX Biggest Gainers

MT Newswires Live

OncoSil Medical Randomizes First South Australia Patient in Pancreatic Cancer Clinical Trial; Shares Up 17%

MT Newswires Live

OncoSil Medical Signs Exclusive Distribution Agreements in Nordics Region, Egypt

MT Newswires Live

BRIEF-Oncosil Medical Signs Distribution Agreements For Nordics And Egypt

Oncosil Medical Ltd - Oncosil Signs Distribution Agreements for Nordics and Egypt

THOMSON REUTERS

Oncosil Medical Ltd-Prospectus 2024 Share Purchase Plan (Spp) Offer

THOMSON REUTERS

Oncosil Medical Ltd-Amended Share Purchase Plan (Spp) Timetable

THOMSON REUTERS

BUZZ-Australia's Oncosil Medical falls on discounted placement

BRIEF-Oncosil Medical Completes A$7 Mln Placement

Oncosil Medical Ltd - Completes a$7 M Placement and Announces a$1 M Spp

THOMSON REUTERS

Oncosil Medical - Share Purchase Plan Offer at an Issue Price of a$0.01 per New Share

THOMSON REUTERS

BRIEF-Oncosil Medical Requests Trading Halt

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/stock/OSL.AU/news"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"OSL.AU"},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"OSL.AU\",,,,,undefined,":{"symbol":"OSL.AU","market":"AU","secType":"STK","nameCN":"ONCOSIL MEDICAL LTD","latestPrice":0.006,"timestamp":1741151520000,"preClose":0.005,"halted":0,"volume":11296298,"delay":0,"changeRate":0.2,"change":0.001,"floatShares":3785725035,"shares":4596580162,"eps":-0.003981,"lyrEps":-0.005367,"pbRate":3.22,"amount":56520,"amplitude":0.4,"volumeRatio":0.7822383345099054,"dividePrice":0,"prevYearClose":0.006,"fiveDayClose":0.006,"twentyDayClose":0.007},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"OSL.AU\",,,,,undefined,":{"symbol":"OSL.AU","floatShares":3785725035,"roa":"-87.77%","roe":"-199.38%","lyrEps":-0.005367,"volumeRatio":0.7822383345099054,"shares":4596580162,"dividePrice":0,"high":0.006,"amplitude":0.4,"preClose":0.005,"low":0.004,"week52Low":0.004,"pbRate":"3.22","psRate":"14.44","week52High":0.015,"institutionHeld":0,"latestPrice":0.006,"committee":-0.991333,"eps":-0.003981,"divideRate":0,"volume":11296298,"delay":0,"ttmEps":-0.003981,"open":0.005,"prevYearClose":0.006,"prevWeekClose":0.006,"prevMonthClose":0.006,"prevQuarterClose":0.006,"fiveDayClose":0.006,"twentyDayClose":0.007,"sixtyDayClose":0.007},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/OSL.AU\",params:#limit:5,,,undefined,":[{"market":"AU","date":"2022-05-05","symbol":"OSL.AU","defaultRemindTime":1651708800000,"type":"split","dateTimestamp":1651672800000,"forFactor":987878,"toFactor":1000000,"ratio":0.987878}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"OSL.AU\",market:\"AU\",,,undefined,":[],"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"OSL.AU\",pageSize:16,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2508921103","title":"OncoSil Medical Says 120 German Hospitals Secure Authorization to Negotiate Fee for Cancer Treatment Device; Shares Surge 40%","url":"https://stock-news.laohu8.com/highlight/detail?id=2508921103","media":"MT Newswires Live","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2508921103?lang=en_us&edition=fundamental","pubTime":"2025-02-04 09:39","pubTimestamp":1738633147,"startTime":"0","endTime":"0","summary":"OncoSil Medical (ASX:OSL) said the German Institute for the Hospital Remuneration System authorized 120 German hospitals to negotiate fees for the OncoSil device classification under the NUB innovatio","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK7508","BK7048","OSL.AU"],"gpt_icon":0},{"id":"2507574349","title":"OncoSil Medical Receives Medical Device Regulation Certification; Shares Surge 20%","url":"https://stock-news.laohu8.com/highlight/detail?id=2507574349","media":"MT Newswires Live","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2507574349?lang=en_us&edition=fundamental","pubTime":"2025-01-29 10:24","pubTimestamp":1738117478,"startTime":"0","endTime":"0","summary":"OncoSil Medical  received Medical Device Regulation certification from the European Union notified body BSI Group, according to a Tuesday filing with the Australian bourse.The certification includes the lifting of existing post-market restrictions for the OncoSil cancer treatment device, simplifying the initiation of commercial treatments, the filing said.The certification also offers the company a chance to re-submit its application to the Therapeutic Goods Administration for Australian market approval, according to the filing.Oncosil shares surged 20% in recent trade Wednesday.Price : $0.01, Change: $+0.0010, Percent Change: +20.00%","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["LU0345774631.USD","LU0426417589.USD","XKO.AU","LU0426412945.USD","LU1043141123.HKD","LU0994945656.USD","OSL.AU","BK7508","BK7048","XJO.AU","LU2238339852.HKD","XAO.AU","BK4125","AUD"],"gpt_icon":0},{"id":"2506530526","title":"BRIEF-Oncosil Medical Receives Mdr Approval","url":"https://stock-news.laohu8.com/highlight/detail?id=2506530526","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2506530526?lang=en_us&edition=fundamental","pubTime":"2025-01-28 09:10","pubTimestamp":1738026655,"startTime":"0","endTime":"0","summary":"BRIEF-Oncosil Medical Receives Mdr ApprovalJan 28 (Reuters) - Oncosil Medical Ltd OSL.AX:ONCOSIL MEDICAL RECEIVES MDR APPROVALFurther company coverage: OSL.AX ((Reuters.Briefs@thomsonreuters.com;))","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250128:nFWN3ON0DQ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK7048","OSL.AU","BK7508"],"gpt_icon":0},{"id":"2506536993","title":"Oncosil Medical Ltd - Oncosil Medical Receives mDR Approval","url":"https://stock-news.laohu8.com/highlight/detail?id=2506536993","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2506536993?lang=en_us&edition=fundamental","pubTime":"2025-01-28 06:58","pubTimestamp":1738018694,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250127:nFWN3ON0DQ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["OSL.AU","BK7508","BK7048"],"gpt_icon":0},{"id":"2500969514","title":"ASX Biggest Gainers","url":"https://stock-news.laohu8.com/highlight/detail?id=2500969514","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2500969514?lang=en_us&edition=fundamental","pubTime":"2025-01-02 09:52","pubTimestamp":1735782724,"startTime":"0","endTime":"0","summary":"Here are the 10 ASX-listed companies with the biggest gains on Friday:Ausmon Resources : +100%, AU$0.0020Eden Innovations : +100%, AU$0.0020Avecho Biotechnology  : +50%, AU$0.0030Lycaon Resources : +50%, AU$0.1350Antilles Gold : +33%, AU$0.0040AuKing Mining : +25%, AU$0.0050Metgasco : +25%, AU$0.0050Hubify : +22%, AU$0.0110OncoSil Medical : +16.7%, AU$0.0070Apollo Minerals : +16.7%, AU$0.0140","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK7509","EDE.AU","AVE.AU","BK7142","BK7096","BK7083","MEL.AU","BK7095","BK7104","BK7048","AOA.AU","OSL.AU","AON.AU","AAU.AU","AKN.AU","BK7508","LYN.AU","HFY.AU","BK7042"],"gpt_icon":0},{"id":"2495885685","title":"OncoSil Medical Randomizes First South Australia Patient in Pancreatic Cancer Clinical Trial; Shares Up 17%","url":"https://stock-news.laohu8.com/highlight/detail?id=2495885685","media":"MT Newswires Live","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2495885685?lang=en_us&edition=fundamental","pubTime":"2024-12-31 08:33","pubTimestamp":1735605198,"startTime":"0","endTime":"0","summary":"OncoSil Medical  randomized the first patient at Royal Adelaide Hospital in South Australia for the TRIPP-FFX clinical trial for pancreatic cancer treatment, marking the start of patient recruitment at the hospital, according to a Tuesday filing with the Australian bourse.The trial aims to evaluate the safety and effectiveness of the OncoSil device in conjunction with Folfirinox chemotherapy, the filing said.Royal Adelaide Hospital's first randomized patient has increased the global TRIPP-FFX trial enrollment to 49, according to the filing.Shares rose nearly 17% in morning trade Tuesday.","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK7508","XKO.AU","XAO.AU","BK7048","XJO.AU","OSL.AU"],"gpt_icon":0},{"id":"2484699553","title":"OncoSil Medical Signs Exclusive Distribution Agreements in Nordics Region, Egypt","url":"https://stock-news.laohu8.com/highlight/detail?id=2484699553","media":"MT Newswires Live","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2484699553?lang=en_us&edition=fundamental","pubTime":"2024-11-18 12:13","pubTimestamp":1731903233,"startTime":"0","endTime":"0","summary":"OncoSil Medical (ASX:OSL) signed agreements with CardiRad and Femto Trade for the exclusive distribution of its brachytherapy treatment to the Nordics region and Egypt, respectively, according to a Monday filing with the Australian bourse.Brachytherapy is a radiation therapy for cancer.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["XJO.AU","BK7508","OSL.AU","XKO.AU","BK7048","XAO.AU"],"gpt_icon":0},{"id":"2484664456","title":"BRIEF-Oncosil Medical Signs Distribution Agreements For Nordics And Egypt","url":"https://stock-news.laohu8.com/highlight/detail?id=2484664456","media":"Reuters","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2484664456?lang=en_us&edition=fundamental","pubTime":"2024-11-18 09:04","pubTimestamp":1731891849,"startTime":"0","endTime":"0","summary":"BRIEF-Oncosil Medical Signs Distribution Agreements For Nordics And EgyptNov 18 (Reuters) - Oncosil Medical Ltd OSL.AX:ONCOSIL SIGNS DISTRIBUTION AGREEMENTS FOR NORDICS AND EGYPTSIGNED DISTRIBUTION AGREEMENTS WITH CARDIRADFurther company coverage: OSL.AX ((Reuters.Briefs@thomsonreuters.com;))","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20241118:nFWN3MO02T:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["OSL.AU","BK7048","BK7508"],"gpt_icon":0},{"id":"2484651933","title":"Oncosil Medical Ltd - Oncosil Signs Distribution Agreements for Nordics and Egypt","url":"https://stock-news.laohu8.com/highlight/detail?id=2484651933","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2484651933?lang=en_us&edition=fundamental","pubTime":"2024-11-18 05:25","pubTimestamp":1731878737,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20241117:nFWN3MO02T:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["OSL.AU","BK7048","BK7508"],"gpt_icon":0},{"id":"2481651865","title":"Oncosil Medical Ltd-Prospectus 2024 Share Purchase Plan (Spp) Offer","url":"https://stock-news.laohu8.com/highlight/detail?id=2481651865","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2481651865?lang=en_us&edition=fundamental","pubTime":"2024-11-06 05:22","pubTimestamp":1730841778,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20241105:nTUE4MDH42:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK7508","OSL.AU","BK7048"],"gpt_icon":0},{"id":"2479782264","title":"Oncosil Medical Ltd-Amended Share Purchase Plan (Spp) Timetable","url":"https://stock-news.laohu8.com/highlight/detail?id=2479782264","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2479782264?lang=en_us&edition=fundamental","pubTime":"2024-10-30 07:03","pubTimestamp":1730242980,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20241029:nTUE9THZQF:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK7048","BK7508","OSL.AU"],"gpt_icon":0},{"id":"2478198721","title":"BUZZ-Australia's Oncosil Medical falls on discounted placement","url":"https://stock-news.laohu8.com/highlight/detail?id=2478198721","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2478198721?lang=en_us&edition=fundamental","pubTime":"2024-10-28 09:04","pubTimestamp":1730077441,"startTime":"0","endTime":"0","summary":"** Shares of Oncosil Medical    fall as much as 26.9% to A$0.01, their lowest since Aug. 12    ** Stock marks its weakest trading session since April 23    ** Medical device maker says it has commitments for a placement of A$7 mln  at A$0.01 per share, and proposes to undertake a share purchase plan to raise about A$1 mln at the same price    ** Offer price at a 23.1% discounts to its last close on Oct. 23, before a trading halt was placed    ** About 32 mln shares change hands, compared with the 30-day average volume of 6.8 mln    ** Stock has risen 17.6% YTD ","market":null,"thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["OSL.AU","XJO.AU","BK7508","BK7048","XKO.AU","XAO.AU"],"gpt_icon":0},{"id":"2478119842","title":"BRIEF-Oncosil Medical Completes A$7 Mln Placement","url":"https://stock-news.laohu8.com/highlight/detail?id=2478119842","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2478119842?lang=en_us&edition=fundamental","pubTime":"2024-10-28 09:01","pubTimestamp":1730077281,"startTime":"0","endTime":"0","summary":"Oct 28 (Reuters) - Oncosil Medical Ltd   :   * COMPLETES A$7 M PLACEMENT AND ANNOUNCES A$1 M SPP   * SHARE PURCHASE PLAN OFFER AT AN ISSUE PRICE OF A$0.01 PER NEW SHAREFurther company coverage:    ((Reuters.Briefs@thomsonreuters.com;))","market":null,"thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK7048","OSL.AU","BK7508"],"gpt_icon":0},{"id":"2478494194","title":"Oncosil Medical Ltd -  Completes a$7 M Placement and Announces a$1 M Spp","url":"https://stock-news.laohu8.com/highlight/detail?id=2478494194","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2478494194?lang=en_us&edition=fundamental","pubTime":"2024-10-28 06:05","pubTimestamp":1730066739,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20241027:nFWN3M12EW:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK7048","BK7508","OSL.AU"],"gpt_icon":0},{"id":"2478194413","title":"Oncosil Medical - Share Purchase Plan Offer at an Issue Price of a$0.01 per New Share","url":"https://stock-news.laohu8.com/highlight/detail?id=2478194413","media":"THOMSON REUTERS","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2478194413?lang=en_us&edition=fundamental","pubTime":"2024-10-28 06:05","pubTimestamp":1730066739,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20241027:nFWN3M12EW:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK7048","OSL.AU","BK7508"],"gpt_icon":0},{"id":"2477251134","title":"BRIEF-Oncosil Medical Requests Trading Halt","url":"https://stock-news.laohu8.com/highlight/detail?id=2477251134","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2477251134?lang=en_us&edition=fundamental","pubTime":"2024-10-24 09:17","pubTimestamp":1729732631,"startTime":"0","endTime":"0","summary":"Oct 24 (Reuters) - Oncosil Medical Ltd   :   * REQUESTS TRADING HALT PENDING CAPITAL RAISE ANNOUNCEMENT Further company coverage:    ((Reuters.Briefs@thomsonreuters.com;))","market":null,"thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["OSL.AU","BK7048","BK7508"],"gpt_icon":0}],"pageSize":16,"totalPage":2,"pageCount":1,"totalSize":25}]}}